Nadia Castaldo Selected Research

Nadia Castaldo Research Topics

Disease

10	Infections 12/2023 - 04/2018
4	COVID-19 11/2023 - 07/2020
3	Pneumonia (Pneumonitis) 02/2024 - 01/2018
2	Urinary Tract Infections (Urinary Tract Infection) 12/2023 - 01/2017
2	Pseudomonas Infections 12/2023 - 04/2019
2	Ventilator-Associated Pneumonia 01/2022 - 01/2018
2	Sepsis (Septicemia) 01/2022 - 04/2019
1	Barotrauma 11/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Liver Failure 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Bacterial Infections (Bacterial Infection) 04/2022
1	Anastomotic Leak 04/2022
1	Healthcare-Associated Pneumonia 01/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Pulmonary Embolism 12/2021
1	Disease Progression 12/2021
1	Pneumothorax 09/2021
1	Malaria 11/2020
1	Respiratory Insufficiency (Respiratory Failure) 07/2020
1	Human Influenza (Influenza) 10/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Fever (Fevers) 04/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Soft Tissue Infections 01/2017

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2017
5	tazobactam drug combination ceftolozaneIBA 01/2022 - 01/2017
4	Carbapenems (Carbapenem Antibiotics)IBA 12/2022 - 01/2020
3	Antiviral Agents (Antivirals)IBA 12/2021 - 10/2019
2	cefepime-zidebactamIBA 12/2023 - 12/2021
2	ceftazidime drug combination avibactamIBA 12/2021 - 01/2020
2	SteroidsIBA 01/2021 - 11/2020
1	murepavadinIBA 12/2023
1	SolutionsIBA 12/2023
1	Oxygen (Dioxygen)IBA 11/2023
1	TetracyclinesIBA 02/2023
1	TeicoplaninIBA 02/2023
1	Chloramphenicol (Chloromycetin)FDA Link 02/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2023
1	Clindamycin (Cleocin)FDA LinkGeneric 02/2023
1	Vancomycin FDA LinkGeneric 02/2023
1	SiderophoresIBA 12/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2022
1	CefiderocolIBA 12/2022
1	omadacyclineIBA 12/2021
1	enmetazobactamIBA 12/2021
1	avibactamIBA 12/2021
1	plazomicinIBA 12/2021
1	eravacyclineIBA 12/2021
1	Cefepime (Maxipime)FDA LinkGeneric 12/2021
1	Ceftaroline FDA Link 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	AnticoagulantsIBA 12/2021
1	Aztreonam FDA LinkGeneric 12/2021
1	ElementsIBA 12/2021
1	Immunomodulating AgentsIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	Lopinavir FDA Link 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	cobicistat mixture with darunavirIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2020
1	Neuraminidase (Sialidase)IBA 10/2019
1	Linezolid (Zyvox)FDA Link 01/2019
1	tedizolid phosphateIBA 01/2019
1	Oxazolidinones (2 Oxazolidone)IBA 01/2019
1	tedizolidIBA 01/2019
1	Amikacin (A.M.K)FDA LinkGeneric 04/2018
1	Investigational DrugsIBA 01/2018
1	LactamsIBA 01/2017

Therapy/Procedure

8	Therapeutics 12/2023 - 04/2018
2	Length of Stay 11/2023 - 01/2023
2	Noninvasive Ventilation 11/2023 - 12/2021
1	Artificial Respiration (Mechanical Ventilation) 11/2023
1	Parenteral Nutrition 04/2022
1	Continuous Positive Airway Pressure 12/2021
1	Pneumonectomy (Lung Volume Reduction) 09/2021
1	Continuous Renal Replacement Therapy 04/2019
1	Heart-Assist Devices 04/2018
1	Transplantation 04/2018